← Back to Search

E1 polyethylene for Arthritis of Hip

N/A
Waitlist Available
Led By Henrik Malchau, MD, PhD
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 years
Awards & highlights

Study Summary

This trial will study 50 patients receiving new hip replacements, specifically testing the durability of a new acetabular insert. Results will be measured using RSA and Martell analysis techniques.

Eligible Conditions
  • Arthritis of Hip
  • Hip Osteoarthritis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Short-term femoral head penetration,long-term steady state wear of polyethylene. Stability of acetabular & femoral components. Clinical questionnaires to assess preop,clinical outcomes,& patient satisfaction.

Trial Design

1Treatment groups
Active Control
Group I: E1 polyethyleneActive Control1 Intervention
All patients received an E1 polyethylene liner which is the material being monitored in this study.

Find a Location

Who is running the clinical trial?

Massachusetts General HospitalLead Sponsor
2,929 Previous Clinical Trials
13,198,255 Total Patients Enrolled
Zimmer BiometIndustry Sponsor
373 Previous Clinical Trials
67,345 Total Patients Enrolled
Henrik Malchau, MD, PhDPrincipal InvestigatorMassachusetts General Hospital
1 Previous Clinical Trials
360 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Evaluation of the Wear of Vitamin E Treated Polyethylene Components in Primary THA Using RSA
Henrik Malchau 2007. "Evaluation of the Wear of Vitamin E Treated Polyethylene Components in Primary THA Using RSA". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT00551967.
~3 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top